Company: BLTE
Filing Date: 2025-03-17
Form Type: 20-F
Source: 0001410578-25-000356
Chunk: 12

Company: BELITE BIO, INC
Filing Date: 2025-03-17
Form: 20-F
Item: Item 16K
Chunk 12
---
 Exhibit 10.1 from our registration statement on Form F-1 (File No. 333-264134), as amended, initially fi...  
      4.2      2022 Performance Incentive Plan ( incorporated by reference to Exhibit 10.2 from our registration statement on Form F-1 (File No. 333-264134), as amended, initially filed publicly with the SEC ...  
      4.3      Form of Employment Agreement between the Registrant and its executive officers ( incorporated by reference to Exhibit 10.3 from our registration statement on Form F-1 (File No. 333-264134), as ...  
      4.4      Form of Indemnification Agreement between the Registrant and its directors and executive officers ( incorporated by reference to Exhibit 10.4 from our registration statement on Form F-1 (File N...  
      4.5      Series A Preferred Share Purchase and Note Conversion Agreement by and among Belite Bio, Inc and certain investors of Belite Bio, Inc named therein dated January 21, 2020 ( incorporated by refe...  
      4.6      Series B Preferred Share Purchase Agreement by and among Belite Bio, Inc and certain investors of Belite Bio, Inc named therein dated December 23, 2020 ( incorporated by reference to Exhibit 10...  
      4.7      Exclusive License Agreement by and between Belite Bio, Inc and The Trustees of Columbia University in The City of New York dated September 13, 2016 ( incorporated by reference to Exhibit 10.7 f...  
      4.8      Amendment to Exclusive License Agreement by and between Belite Bio, Inc and The Trustees of Columbia University in The City of New York dated August 15, 2017 ( incorporated by reference to Exhi...  
      4.9      Letter of Consent issued by The Trustees of Columbia University in The City of New York dated May 3, 2018 ( incorporated by reference to Exhibit 10.9 from our registration statement on Form F-1...